Bachem, CH0012530207

Bachem stock heads into the open near Barclays CHF 80 target

Published on 09/10/2026 at 06:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the quote snapshot on September 9, 2026, Bachem stock traded around CHF 78.40 on SIX Swiss Exchange, down about 0.25 percent intraday, while sitting within the upper band of a CHF 50.00 to CHF 83.80 52 week range and just below Barclays CHF 80 price target.

Fotorealistische Peptid-Produktionsanlage mit Alpenpanorama im Hintergrund
Bachem Holding AG (CH0012530207) betreibt moderne Peptid-Produktionsanlagen mit Bioreaktoren vor Schweizer Alpenpanorama, Illustration mit AI erstellt.

Bachem stock was quoted at CHF 78.40 on SIX Swiss Exchange on September 9, 2026, reflecting an intraday decline of roughly 0.25 percent versus the prior close of CHF 78.60 per exchange data summarized by Yahoo Finance.

According to Ad-hoc-news, this CHF 78.40 level on September 9, 2026 left the shares trading within the upper segment of a CHF 50.00 to CHF 83.80 52 week range and roughly two percent below the CHF 80.00 price target maintained by Barclays.

September 9, 2026 in numbers

Bachem Holding AG (ISIN CH0012530207) was quoted at CHF 78.40 on September 9, 2026 on SIX Swiss Exchange, compared with a prior closing level of CHF 78.60, implying a negative move of CHF 0.20 or about 0.25 percent that session based on data from Yahoo Finance as cited by Ad-hoc-news.

Per the same summary of SIX Swiss Exchange data, Bachem shares on September 9, 2026 traded around CHF 78 to CHF 79 during the session and stood within the upper part of a CHF 50.00 to CHF 83.80 52 week range, underscoring a strong longer term performance profile relative to earlier levels reported for the year by Yahoo Finance as relayed through Ad-hoc-news.

The same report notes that year to date on September 9, 2026 Bachem stock had gained about 32.57 percent, while the MSCI World index was up roughly 11.29 percent, meaning Bachem outperformed the global equity benchmark by more than 20 percentage points over that period according to performance data compiled by Yahoo Finance and relayed by Ad-hoc-news.

As IT-Boltwise reported on September 9, 2026, Barclays reiterated a Hold rating on Bachem Holding AG with a price target of CHF 80.00, aligning with a broader analyst consensus that also centers around a CHF 80.00 target for the shares.

Today's outlook for Bachem

The reiterated Hold rating and CHF 80.00 price target from Barclays on September 9, 2026, as described by IT-Boltwise, remain a key reference for investors heading into today's SIX Swiss Exchange session, with the stock trading close to that level at the latest quote snapshot.

Bachem also continues to appear at industry gatherings, with the company listed as a participant at events such as Nordic Life Science Days on September 8, 2026 in its events archive according to Bachem, underscoring ongoing engagement with the broader life sciences community that can shape sentiment over the medium term even if no specific market moving corporate release is dated for September 10, 2026 in the available records.

Disclaimer...

en | CH0012530207 | BACHEM | boerse | 70079175 | bgmi